AHRQ Antidepressant Report May Put Pressure On CMS Formulary Guidelines
An Agency for Healthcare Research & Quality draft report finding no substantial efficacy difference among second-generation antidepressants could increase pressure on CMS' "all or substantially all" coverage policy for the class